Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its guidance for 2025. The stock ...
The halo effect, a bias where one positive trait skews perception, impacts decisions in hiring, marketing, and relationships.
Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback